A carregar...
The Subcontinental Surge
Biotech is following big pharma to India, where R&D costs are a fraction of those in the U.S. India itself is working hard to make it happen. Ultimately, this could reduce the price of biotech therapies. But what about India’s reputation for disregarding intellectual property rights?
Na minha lista:
| Autor principal: | |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioCommunications LLC
2004
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3564301/ https://ncbi.nlm.nih.gov/pubmed/23393438 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|